Medicaid's Addiction Treatment Billing Tripled and Stayed Uneven

Two numbers that don't belong together: Scioto County Counseling Center in Portsmouth, Ohio billed $104,518,319 in intensive outpatient services alone. Hartford Dispensary in Hartford, Connecticut billed $122,555,102 across more than 10.7 million claims. Both are among the largest Medicaid substance use disorder billers in the country. Neither uses the same treatment codes as the other. That divergence is the story.

California, Maryland, and the Per-Claim Gap That Defies Easy Explanation

Start with the state-level picture. California led all states in Medicaid H0020 opioid treatment spending in 2018, recording $145,169,765 across 8,375,906 claims. Massachusetts ranked second at $74,794,931 across 5,502,741 claims. Maryland came in third at $70,826,825, but generated only 1,086,030 claims to get there.

That arithmetic is striking. Maryland produced roughly the same dollar volume as Massachusetts while processing less than one-fifth the claims. California's implied per-claim rate across its 8.4 million H0020 claims is a fraction of Maryland's. For analysts tracking whether Medicaid reimbursement is reaching patients or concentrating in high-rate billing arrangements, that gap demands scrutiny. A state spending $70 million through one million claims is structurally different from a state spending $145 million through eight million, even if the headline numbers look comparable.

Connecticut's $56,053,778 in H0020 spending in 2018 was less than half of California's, but a single organization, Hartford Dispensary, billed $122,555,102 in H0020 methadone codes across the entire measured period. That one provider's cumulative total exceeds Connecticut's entire 2018 state figure by more than double.

One Code, One Provider, $104 Million

The provider-level data is where concentration becomes impossible to ignore.

Los Angeles County Department of Public Health is the single largest Medicaid SUD billing organization in this data, at $131,877,522 across opioid and intensive outpatient codes. That's a county public health agency operating at a scale most state systems don't approach.

Pyramid Health Care in Pennsylvania billed $101,596,706 entirely through H2036 alcohol and drug services codes, across only 343,324 claims. Hartford Dispensary billed $122,555,102 across 10,731,627 claims. Same approximate dollar range, thirty times the claim volume. The implied per-claim rate for Pyramid is roughly 31 times higher than Hartford Dispensary's. Whether that reflects different service intensities, different patient populations, or different billing practices, the data alone can't resolve, but the gap is large enough that any audit framework would flag it immediately.

Scioto County Counseling Center's profile is equally unusual. Zero H0020 methadone billing. $104,518,319 in intensive outpatient. That's a single counseling center in a small Ohio county generating more in one treatment category than most state Medicaid programs spend on addiction services in a year. For context, Vermont's Habit OPCO LLC in Brattleboro billed $55,838,656 entirely through methadone codes across 3,332,603 claims, roughly half of Scioto's total through a completely different treatment pathway.

Infrastructure Follows Infrastructure

The pattern across both state and provider data points in the same direction. Medicaid SUD dollars are flowing to organizations and states that already had billing infrastructure, established provider networks, and high claim volumes. California, Massachusetts, and Maryland collectively dominated 2018 H0020 spending. The top five individual providers span California, Connecticut, Ohio, Missouri, and Pennsylvania, all states with mature Medicaid managed care or fee-for-service SUD frameworks.

What this means in practice: a county counseling center in rural Ohio can generate nine-figure Medicaid billings while states without comparable infrastructure remain absent from the top-tier data entirely. The money is real. The access it represents may not be evenly distributed.

Given that Maryland generated $70,826,825 in H0020 spending from only 1,086,030 claims in 2018, implying a per-claim rate several times higher than California's across 8,375,906 claims, what explains the dramatic difference in per-claim reimbursement rates across states, and are those differences producing proportionally better patient outcomes?